Results 11 to 20 of about 1,212 (129)

Anesthesia and Cancer, Friend or Foe? A Narrative Review

open access: yesFrontiers in Oncology, 2021
Cancer remains the leading cause of death worldwide with close to 10 million deaths reported annually. Due to growth of the advanced age cohort in our population, it is predicted that the number of new cancer cases diagnosed between now until 2035 is to ...
Julio Montejano   +1 more
doaj   +1 more source

Central sympatholytics prolong survival in experimental sepsis [PDF]

open access: yes, 2009
Introduction One of the main causes of death in European and US intensive care units is sepsis. It involves a network of pro-inflammatory cytokines such as TNF-alpha, IL-1 beta and IL-6.
Martin, Eike   +17 more
core   +1 more source

Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial

open access: yesBMC Endocrine Disorders, 2020
Background Sympathetic activity and insulin resistance have recently been linked with chronic tendon and musculoskeletal pain. Polycystic ovarian syndrome is linked with insulin resistance and increased sympathetic drive and was therefore an appropriate ...
Jacob Jewson   +6 more
doaj   +1 more source

Evaluation of Nebulised Dexmedetomidine in Blunting Haemodynamic Response to Laryngoscopy and Intubation in Adults Undergoing General Anaesthesia for Laparoscopic Surgeries: A Randomised Control Trial [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Laryngoscopy and endotracheal intubation can trigger sympathetic stimulation, potentially leading to cardiovascular or cerebrovascular complications in high-risk patients.
Et Muhammed Jaseel   +3 more
doaj   +1 more source

Effect of Infusion of Dexmedetomidine on Succinylcholine-induced Fasciculation and Myalgia in ENT Surgeries: A Research Protocol [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Succinylcholine, a depolarising neuromuscular blocker, is widely used to facilitate rapid sequence intubation due to its rapid onset and short duration of action.
Kola Kavya Praneetha, Jayashree Sen
doaj   +1 more source

Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics

open access: yes, 2009
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development of glaucoma and a wide range of options are now available to reduce it: medical treatment, laser, filtering, or cyclodestructive surgery (alone or in ...
Parmeggiani F.   +21 more
core   +2 more sources

Pharmacologic pitfalls in heart failure: a guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document [PDF]

open access: yes
Heart failure (HF) exerts a global health burden, often complicated by polypharmacy due to the frequent coexistence of cardiovascular and non-cardiovascular comorbidities.
Hadi Skouri (5314571)   +16 more
core   +3 more sources

Nasal airflow in health and disease

open access: yes, 2000
This review examines our present understanding of the physiology, pathophysiology and pharmacology of nasal airflow. The main aim of the review is to discuss the basic scientific and clinical knowledge that is essential for a proper understanding of the ...
Eccles, Ronald, Ronald Eccles
core   +1 more source

Cardiovascular complications during equine anaesthesia: From pre‐anaesthetic assessment to recovery

open access: yesEquine Veterinary Education, EarlyView.
Summary Cardiac leiomyosarcoma is an exceptionally rare neoplasm in equids. The case report by Carroll et al. (2026; Equine Veterinary Education, 38, e686) in the October issue describes a mule that suffered fatal cardiovascular collapse during recovery, with post‐mortem examination revealing a cardiac leiomyosarcoma and severe pericardial effusion ...
P. M. C. Tomás, L. F. Louro
wiley   +1 more source

Next Step in Chronic Kidney Disease Therapy

open access: yes, 2016
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers are the basis of renoprotection therapy in chronic kidney disease. Parallel to decrease of glomerular filtration rate, there is an increase in the activity of the sympathetic nervous ...
D.D. Ivanov
core   +1 more source

Home - About - Disclaimer - Privacy